Recent Developments in the Field of Radiotherapy Treatment for Lung Cancer
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 10 February 2026 | Viewed by 18
Special Issue Editor
Interests: stem cells; pagreatic cancer
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Lung cancer is the leading cause of cancer-related death, with non-small-cell lung cancer (NSCLC) coming out on top according to the 2020 global cancer statistics; this type represents 80–85% of all lung cancers globally. Radiotherapy, an important component of the multidisciplinary management of lung cancer, plays a critical role in the entire treatment process for these patients. In recent years, guided by the principle of multidisciplinary and personalized precision treatment strategies, the role of radiotherapy has expanded from local regional tumor control or symptom palliation in the past to systemic immunomodulation when combined with immunotherapy in modern practice.
This Special Issue examines the current role of radiotherapy in lung cancer, discusses the evidence behind this, and identifies future directions in the radiotherapy treatment of lung cancer.
Original articles, comprehensive reviews, and systematic reviews will be considered for publication.
We look forward to receiving your contributions.
Dr. Ioannis C. Maroulis
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- lung cancer
- radiotherapy
- non-small-cell lung cancer (NSCLC)
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
